Sold 34,535 @ $18.54 avg · $640,279 · 2026-09-14
Form 4: Duprey Lauren Rusckowski sold TAK
Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 34,535 shares of TAK at an average $18.54, roughly $640,279, in a Form 4 filed 2026-09-15.
At post $18.70·Now $18.91+1.1% since postedas of Sep 18, 4:31 PM ET
1d-0.3%
3d+1.1%
1w—
1m—
3m—
6m—
1y—
Sold 16,901 @ $17.10 avg · $289,007 · 2026-08-10
Form 4: Pacheco Rhonda Janice sold TAK
Pacheco Rhonda Janice (President, U.S. Business Unit at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 16,901 shares of TAK at an average $17.10, roughly $289,007, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 47,586 @ $17.10 avg · $813,721 · 2026-08-10
Form 4: Duprey Lauren Rusckowski sold TAK
Duprey Lauren Rusckowski (Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 47,586 shares of TAK at an average $17.10, roughly $813,721, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 165,393 @ $17.10 avg · $2,828,220 · 2026-08-10
Form 4: Plump Andrew Stewart sold TAK
Plump Andrew Stewart (President, R&D at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 165,393 shares of TAK at an average $17.10, roughly $2,828,220, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 22,957 @ $17.10 avg · $392,565 · 2026-08-10
Form 4: Pignagnoli Agosti Marcello sold TAK
Pignagnoli Agosti Marcello (Head, Strat. & Port. Dev at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 22,957 shares of TAK at an average $17.10, roughly $392,565, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 50,012 @ $17.10 avg · $855,205 · 2026-08-10
Form 4: Bitetti Teresa Marie sold TAK
Bitetti Teresa Marie (President, OBU at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 50,012 shares of TAK at an average $17.10, roughly $855,205, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 25,088 @ $17.10 avg · $429,005 · 2026-08-10
Form 4: Ricci Gabriele sold TAK
Ricci Gabriele (Chief Data & Tech. Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 25,088 shares of TAK at an average $17.10, roughly $429,005, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 89,090 @ $17.10 avg · $1,523,439 · 2026-08-10
Form 4: Kim Julie So-Young sold TAK
Kim Julie So-Young (President and CEO at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 89,090 shares of TAK at an average $17.10, roughly $1,523,439, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 31,083 @ $17.10 avg · $531,519 · 2026-08-10
Form 4: Platford Giles Richard sold TAK
Platford Giles Richard (President, IBU at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 31,083 shares of TAK at an average $17.10, roughly $531,519, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 30,868 @ $17.10 avg · $527,843 · 2026-08-10
Form 4: Furney Natalie Anne Marie sold TAK
Furney Natalie Anne Marie (Global General Counsel at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 30,868 shares of TAK at an average $17.10, roughly $527,843, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 20,363 @ $17.55 avg · $357,371 · 2026-08-11
Form 4: Shannon Elaine Mary sold TAK
Shannon Elaine Mary (Pres., Global Supply & Quality at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 20,363 shares of TAK at an average $17.55, roughly $357,371, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—
Sold 34,603 @ $17.51 avg · $605,778 · 2026-08-10
Form 4: Greenway Nicola Deidre Petal sold TAK
Greenway Nicola Deidre Petal (Chief Human Resources Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 34,603 shares of TAK at an average $17.51, roughly $605,778, in a Form 4 filed 2026-08-12.
At post $17.41·Now $18.91+8.6% since postedas of Sep 18, 4:31 PM ET
1d-0.1%
3d+1.3%
1w+5.3%
1m+4.9%
3m—
6m—
1y—